These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10712329)

  • 1. The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists.
    Au DH; Lemaitre RN; Curtis JR; Smith NL; Psaty BM
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):827-30. PubMed ID: 10712329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction.
    Au DH; Curtis JR; Every NR; McDonell MB; Fihn SD
    Chest; 2002 Mar; 121(3):846-51. PubMed ID: 11888971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chronic heart failure and inhaled beta-2-adrenoceptor agonists.
    Au DH; Udris EM; Curtis JR; McDonell MB; Fihn SD;
    Am Heart J; 2004 Nov; 148(5):915-20. PubMed ID: 15523327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids.
    Vestergaard P; Rejnmark L; Mosekilde L
    Chest; 2007 Nov; 132(5):1599-607. PubMed ID: 17890464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction.
    Suissa S; Assimes T; Ernst P
    Thorax; 2003 Jan; 58(1):43-6. PubMed ID: 12511719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension.
    de Vries F; Pouwels S; Bracke M; Lammers JW; Klungel O; Leufkens H; van Staa T
    Br J Clin Pharmacol; 2008 Apr; 65(4):580-6. PubMed ID: 18279472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
    Hui KP
    Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present state of the controversy about regular inhaled beta-agonists in asthma.
    Giuntini CG; Paggiaro PL
    Eur Respir J; 1995 May; 8(5):673-8. PubMed ID: 7656934
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists.
    Appleton SL; Ruffin RE; Wilson DH; Taylor AW; Adams RJ;
    J Allergy Clin Immunol; 2009 Jan; 123(1):124-130.e1. PubMed ID: 19130933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
    Korsgaard J; Ledet M
    Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilators and acute cardiac death.
    Suissa S; Hemmelgarn B; Blais L; Ernst P
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1598-602. PubMed ID: 8970341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.
    Corrao G; Zambon A; Faini S; Bagnardi V; Leoni O; Suissa S
    J Clin Epidemiol; 2005 Jan; 58(1):92-7. PubMed ID: 15649676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction.
    Groenwold RH; de Vries F; de Boer A; Pestman WR; Rutten FH; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1130-7. PubMed ID: 21953948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.